FIELD: chemistry.
SUBSTANCE: invention relates to novel compounds of formula (I): where: X denotes -CH2-, -CH2CH2-; R1 denotes H; R2 and R3 denote H; or one of them denotes H and the other denotes a branched or straight C1-6alkyl, C3-6cycloalkyl or phenyl; where the said C1-6alkyl is possibly substituted with one OH, NH2, C3-6cycloalkyl, phenyl; where any phenyl is possibly substituted with one or two substitutes selected from halogen or C1-6alkyl; R4 denotes H; R5 denotes H, halogen, C1-6alkyl; or a pharmaceutically acceptable salt thereof.
EFFECT: compounds inhibit cholesterol absorption, which enables their use in treating and preventing atherosclerosis.
14 cl, 18 ex
Title | Year | Author | Number |
---|---|---|---|
NOVEL 2-AZETIDINONE DERIVATIVES AS CHOLESTEROL ABSORPTION INHIBITORS FOR TREATING HYPERLIPIDEMIC CONDITIONS | 2006 |
|
RU2409562C2 |
DIPHENYLAZETIDINONE DERIVATIVES HAVING INHIBITORY ACTIVITY TOWARDS CHOLESTEROL ABSORPTION | 2004 |
|
RU2380360C2 |
2,6,9-TRISUBSTITUTED PURINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE CATIONIC SALT, METHOD FOR INHIBITION OF CELL PROLIFERATION, PHARMACEUTICAL COMPOSITION | 1997 |
|
RU2220968C2 |
NEW PIPERIDINES AS CHEMOKINE (CCR) MODULATORS | 2005 |
|
RU2348616C2 |
PIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR CCR5 | 2005 |
|
RU2368608C2 |
CHEMICAL COMPOUNDS | 2006 |
|
RU2405780C2 |
DERIVATIVE OF PHENETHANOLAMINE FOR TREATMENT OF RESPIRATORY DISEASE | 2002 |
|
RU2312854C2 |
COMPOSITIONS AFFECTING GLUCOKINASE | 2002 |
|
RU2329043C9 |
TETRAHYROQUINOLINE ANALOGUES AS MUSCARINIC AGONISTS | 2005 |
|
RU2434865C2 |
SUBSTITUTED DIKETOPIPERAZINES AS OXYTOCIN ANTAGONISTS | 2002 |
|
RU2303032C2 |
Authors
Dates
2011-01-20—Published
2006-06-21—Filed